Led by Santé, the funding will support completion of the world's first randomized HIFU trial for pancreatic cancer, and accelerate U.S. clinical programs for the company's anesthesia-free, outpatient sonic therapy PALO ALTO, Calif., April 15, 2026 /PRNewswire/ -- Sonire Therapeutics, a...
Hence then, the article about sonire therapeutics closes 18 million series a financing to advance breakthrough hifu therapy for pancreatic cancer expands u s clinical development was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Sonire Therapeutics Closes $18 Million Series A Financing to Advance Breakthrough HIFU Therapy for Pancreatic Cancer, Expands U.S. Clinical Development )
Also on site :
- Trump speeds review of psychedelics after Joe Rogan texted him about ibogaine. ‘Sounds great. Do you want FDA approval? Let’s do it’
- Charity Organization Cuts Ties with Sharon Osbourne After She Backs Tommy Robinson’s Anti-Immigration Rally
- Royals To Select Contract Of Elias Díaz